AZ Brushes Off Vaccine Criticism, Awaits US Readout

WHO Endorsement Counters Fears

 
• By Andrew McConaghie
  
AZ Vaccines
AstraZeneca's COVID-19 vaccine: fears on efficacy could be allayed by US Phase III results, expected within the next few weeks.

More from Clinical Trials

More from R&D